Literature DB >> 5660023

The limbal approach to surgery of the rectus muscles.

G K Von Noorden.   

Abstract

Mesh：

Year:  1968        PMID： 5660023     DOI： 10.1001/archopht.1968.00980050096016

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  9 in total

1.  Corneal dellen in the limbal approach to rectus muscle surgery.

Authors:  H H Tessler; M J Urist
Journal:  Br J Ophthalmol       Date:  1975-07       Impact factor: 4.638

2.  Comparison of a new, minimally invasive strabismus surgery technique with the usual limbal approach for rectus muscle recession and plication.

Authors:  D S Mojon
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

3.  Minimally invasive strabismus surgery for rectus muscle posterior fixation.

Authors:  Daniel S Mojon
Journal:  Ophthalmologica       Date:  2008-12-10       Impact factor: 3.250

Review 4.  Review: minimally invasive strabismus surgery.

Authors:  D S Mojon
Journal:  Eye (Lond)       Date:  2014-11-28       Impact factor: 3.775

5.  Colchicine suppression of corneal healing after strabismus surgery.

Authors:  B Z Biedner; L Rothkoff; L Friedman; C Geltman
Journal:  Br J Ophthalmol       Date:  1977-07       Impact factor: 4.638

6.  Limbal incision with conjunctival continuous key-pattern suture in squint surgery.

Authors:  A U Herbstein
Journal:  Br J Ophthalmol       Date:  1972-09       Impact factor: 4.638

7.  Intraoperative conversion rate to a large, limbal opening in minimally invasive strabismus surgery (MISS).

Authors:  Marion Kaup; Stefania M Mojon-Azzi; Andrea Kunz; Daniel S Mojon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-24       Impact factor: 3.117

8.  Minimally invasive Knapp's procedure: modified fornix incision approach.

Authors:  Jitendra Jethani
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

9.  Minimally invasive strabismus surgery for horizontal rectus muscle reoperations.

Authors:  D S Mojon
Journal:  Br J Ophthalmol       Date:  2008-09-09       Impact factor: 4.638
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.